Weakened APC/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition

Colin R Gliech1, Zhong Y Yeow1, Daniel Tapias-Gomez1

  • 1Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

The EMBO Journal
|January 26, 2024
PubMed

Insights

Targeting KIF18A offers a new cancer therapy approach. Inhibiting this motor protein causes mitotic delays, making cancer cells with specific cell division weaknesses vulnerable to treatment.

Area of Science:

  • Cell Biology
  • Cancer Therapeutics
  • Molecular Oncology

Background:

  • Current antimitotic drugs face limitations due to toxicity in healthy tissues.
  • KIF18A, a microtubule motor protein, is a potential cancer therapeutic target due to cancer-specific dependencies.
  • The reasons for varying KIF18A requirement across different cancers are not fully understood.

Purpose of the Study:

  • To investigate the impact of KIF18A inhibition on cancer cell division.
  • To identify the cellular determinants of sensitivity to KIF18A inhibition.
  • To explore KIF18A as a viable therapeutic target by understanding its role in mitotic regulation.

Main Methods:

  • KIF18A inhibition was induced in cancer cells.
  • Spindle assembly checkpoint (SAC) signaling dynamics were analyzed.
  • The metaphase-to-anaphase transition and anaphase-promoting complex/cyclosome (APC/C) activity were assessed.
  • Cellular vulnerabilities related to mitosis were characterized.

Main Results:

  • KIF18A inhibition led to increased SAC signaling and mitotic delays.
  • Cancer cells with weaker APC/C activity or persistent SAC signaling showed heightened sensitivity.
  • KIF18A-dependent cancers displayed hallmarks of SAC:APC/C imbalance, including prolonged metaphase-anaphase transitions.
  • Overall mitosis was slower in sensitive cancer cells.

Conclusions:

  • KIF18A inhibition exploits vulnerabilities in the cancer cell division machinery.
  • The interplay between SAC signaling and APC/C activity dictates sensitivity to KIF18A inhibition.
  • This study reveals a therapeutic strategy targeting specific cell division defects in cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K